Zhejiang Medicine: Invested 157 million yuan to establish a biopharmaceutical fund, focusing on emerging industry sectors

2026-03-10 14:02:40

Abstract generation in progress

Recently, Zhejiang Medicine announced that the company, together with Xiamen Huaben Contemporary Venture Capital Management Co., Ltd. and other limited partners, jointly invested in Xiamen Huaben Qihang Equity Investment Partnership (Limited Partnership). The total committed capital of the partnership is 320 million yuan, of which the company contributed 157 million yuan from its own funds, accounting for 49.06% of the total committed capital.

The announcement mentioned that the partnership’s main investment areas are biomedicine and other strategic emerging industries, with an investment proportion of no less than 60% of the fund size.

(Zhejiang Medicine Announcement)

(Edited by: Yang Yan, Lin Chen)

Keywords: Healthcare

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.